Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

The treatment combination is effective and generally safe for lung cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Promising cancer treatments were found, but the manufacturer closed.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Presurgical models can effectively and affordably screen cancer prevention agents.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

The drug combination was safe and showed promise in treating advanced tumors.

Aumolertinib effectively controls lung cancer and improves quality of life.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.